These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33452761)

  • 1. Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients.
    Zaguirre K; Kai M; Kubo M; Yamada M; Kurata K; Kawaji H; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Morisaki T; Mori H; Oda Y; Chen S; Moriyama T; Shimizu S; Nakamura M
    Cancer Med; 2021 Mar; 10(5):1605-1613. PubMed ID: 33452761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population.
    van Maaren MC; van Steenbeek CD; Pharoah PDP; Witteveen A; Sonke GS; Strobbe LJA; Poortmans PMP; Siesling S
    Eur J Cancer; 2017 Nov; 86():364-372. PubMed ID: 29100191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer.
    Stabellini N; Cao L; Towe CW; Miller ME; Sousa-Santos AH; Amin AL; Montero AJ
    J Natl Compr Canc Netw; 2023 Oct; 21(10):1011-1019.e6. PubMed ID: 37856198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
    Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
    Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the performance of PREDICT tool in a large Mainland Chinese breast cancer cohort: a comparative analysis of versions 3.0 and 2.2.
    Chen E; Chen C; Chen Y; You J; Jin C; Huang Z; Zhang J; Wang Q; Cai Y; Hu X; Li Q
    Oncologist; 2024 Aug; 29(8):e976-e983. PubMed ID: 38943540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer.
    Wishart GC; Rakha E; Green A; Ellis I; Ali HR; Provenzano E; Blows FM; Caldas C; Pharoah PD
    BMC Cancer; 2014 Dec; 14():908. PubMed ID: 25472026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of PREDICT Version 2.2 in a Retrospective Cohort of Indian Women With Operable Breast Cancer.
    Nair NS; Kothari B; Gupta S; Kanann S; Vanmali V; Hawaldar R; Tondare A; Siddique S; Parmar V; Joshi S; Badwe RA
    JCO Glob Oncol; 2023 Sep; 9():e2300114. PubMed ID: 38085062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.
    Gray E; Marti J; Brewster DH; Wyatt JC; Hall PS;
    Br J Cancer; 2018 Oct; 119(7):808-814. PubMed ID: 30220705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.
    Engelhardt EG; van den Broek AJ; Linn SC; Wishart GC; Rutgers EJT; van de Velde AO; Smit VTHBM; Voogd AC; Siesling S; Brinkhuis M; Seynaeve C; Westenend PJ; Stiggelbout AM; Tollenaar RAEM; van Leeuwen FE; van 't Veer LJ; Ravdin PM; Pharaoh PDP; Schmidt MK
    Eur J Cancer; 2017 Jun; 78():37-44. PubMed ID: 28412587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic evaluation of esophageal cancer patients with stages I-III.
    Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
    Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IHC4 score plus clinical treatment score predicts locoregional recurrence in early breast cancer.
    Lakhanpal R; Sestak I; Shadbolt B; Bennett GM; Brown M; Phillips T; Zhang Y; Bullman A; Rezo A
    Breast; 2016 Oct; 29():147-52. PubMed ID: 27498128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
    Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
    Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
    Ogura K; Gokita T; Shinoda Y; Kawano H; Takagi T; Ae K; Kawai A; Wedin R; Forsberg JA
    Clin Orthop Relat Res; 2017 Sep; 475(9):2263-2270. PubMed ID: 28560532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the online prediction model CancerMath in the Dutch breast cancer population.
    Hoveling LA; van Maaren MC; Hueting T; Strobbe LJA; Hendriks MP; Sonke GS; Siesling S
    Breast Cancer Res Treat; 2019 Dec; 178(3):665-681. PubMed ID: 31471837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.
    Wenhui Z; Shuo L; Dabei T; Ying P; Zhipeng W; Lei Z; Xiaohui H; Jingshu G; Hongtao S; Qingyuan Z
    Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive accuracy of PREDICT: a personalized decision-making tool for Southeast Asian women with breast cancer.
    Wong HS; Subramaniam S; Alias Z; Taib NA; Ho GF; Ng CH; Yip CH; Verkooijen HM; Hartman M; Bhoo-Pathy N
    Medicine (Baltimore); 2015 Feb; 94(8):e593. PubMed ID: 25715267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular phenotypes of DCIS predict overall and invasive recurrence.
    Williams KE; Barnes NLP; Cramer A; Johnson R; Cheema K; Morris J; Howe M; Bundred NJ
    Ann Oncol; 2015 May; 26(5):1019-1025. PubMed ID: 25678586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.